Your session is about to expire
← Back to Search
Sitting Ellipticals for Chronic Lower Back Pain (Cubii Trial)
Cubii Trial Summary
This trial looks at how non-weightbearing elliptical exercise affects people with chronic lower back pain, to see if it can improve vital signs, pain, disability, mental health, etc.
Cubii Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowCubii Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Cubii Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Does this experimental research program accept individuals aged 45 and over?
"According the stated entry requirements for this medical analysis, individuals must be between 18 and 70 years old in order to participate."
Is this research study currently in the process of gathering participants?
"Affirmative, the clinicaltrials.gov website states that this research is currently in its recruitment phase. Initially posted on September 18th 2023 and last updated at the same time, 64 patients are needed to be enrolled from a single site."
What are the hoped-for outcomes of this medical experiment?
"This 8-week trial aims to quantify patient pain using the Visual Analogue Scale (VAS). Other metrics that will be tracked include total strides, time series of stride/minute, and average strides/minute."
What criteria must a patient satisfy to be eligible for this experiment?
"This clinical trial seeks 64 adults aged 18-70 who are experiencing chronic lower back pain and meet the anatomical criteria of being located between the costal margins and inferior gluteal folds."
To what extent is the populace participating in this research?
"Affirmative. Clinicaltrials.gov confirms that this medical study, posted on September 18th 2023 and updated recently on the same date, is actively recruiting participants. A total of 64 patients are needed to be enrolled from 1 location across the world."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
How responsive is this trial?
Average response time
- < 1 Day
Most responsive sites:
- Massachusetts General Hospital: < 24 hours
Typically responds via
Share this study with friends
Copy Link
Messenger